Award recordCONTRACT

TRIAD ISOTOPES, INC.

PIID VA69D16C0058· VHA· 252-NETWORK CONTRACT OFFICE 12 (36C252)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2016· $689,732 net obligations· UEI EQ4VSLH8RC33· FL

Description

RADIOPHARMACEUTICALS

First action · last action
2016-01-15 · 2020-04-24
Transactions
15
First transaction's obligation
$177,224
Base + all options value (sum of deltas)
$689,732
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 15 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$720,027$0Base award · 2016-01-15 · this action $177,224 · running total $177,224Modification P00001 · 2016-01-29 · this action $0 · running total $177,224Modification P00002 · 2017-01-05 · this action $121,000 · running total $298,224Modification P00003 · 2017-01-23 · this action $2,122 · running total $300,347Modification P00004 · 2017-03-01 · this action $15,353 · running total $315,700Modification P00005 · 2017-03-28 · this action $0 · running total $315,700Modification P00006 · 2017-06-28 · this action $61,000 · running total $376,700Modification P00007 · 2017-10-03 · this action $70,000 · running total $446,700Modification P00008 · 2018-01-30 · this action $135,000 · running total $581,700Modification P00009 · 2018-03-02 · this action $8,327 · running total $590,027Modification P00010 · 2018-08-30 · this action $40,000 · running total $630,027Modification P00011 · 2018-10-01 · this action $90,000 · running total $720,027Modification P00012 · 2018-10-11 · this action $0 · running total $720,027Modification P00013 · 2019-08-02 · this action -$23,757 · running total $696,271Modification P00014 · 2020-04-24 · this action -$6,539 · running total $689,732
  • Base2016-01-15+$177,224= $177,224
  • Mod P000012016-01-29+$0= $177,224
  • Mod P000022017-01-05+$121,000= $298,224
  • Mod P000032017-01-23+$2,122= $300,347
  • Mod P000042017-03-01+$15,353= $315,700
  • Mod P000052017-03-28+$0= $315,700
  • Mod P000062017-06-28+$61,000= $376,700
  • Mod P000072017-10-03+$70,000= $446,700
  • Mod P000082018-01-30+$135,000= $581,700
  • Mod P000092018-03-02+$8,327= $590,027
  • Mod P000102018-08-30+$40,000= $630,027
  • Mod P000112018-10-01+$90,000= $720,027
  • Mod P000122018-10-11+$0= $720,027
  • Mod P000132019-08-02-$23,757= $696,271
  • Mod P000142020-04-24-$6,539= $689,732
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-01-15+$177,224$177,224RADIOPHARMACEUTICALS
Mod P00001· CHANGE ORDER2016-01-29+$0$177,224RADIOPHARMACEUTICALS
Mod P00002· EXERCISE AN OPTION2017-01-05+$121,000$298,224RADIOPHARMACEUTICALS
Mod P00003· OTHER ADMINISTRATIVE ACTION2017-01-23+$2,122$300,347RADIOPHARMACEUTICALS
Mod P00004· FUNDING ONLY ACTION2017-03-01+$15,353$315,700RADIOPHARMACEUTICALS
Mod P00005· OTHER ADMINISTRATIVE ACTION2017-03-28+$0$315,700RADIOPHARMACEUTICALS
Mod P00006· FUNDING ONLY ACTION2017-06-28+$61,000$376,700RADIOPHARMACEUTICALS
Mod P00007· FUNDING ONLY ACTION2017-10-03+$70,000$446,700RADIOPHARMACEUTICALS
Mod P00008· EXERCISE AN OPTION2018-01-30+$135,000$581,700RADIOPHARMACEUTICALS
Mod P00009· OTHER ADMINISTRATIVE ACTION2018-03-02+$8,327$590,027RADIOPHARMACEUTICALS
Mod P00010· FUNDING ONLY ACTION2018-08-30+$40,000$630,027RADIOPHARMACEUTICALS
Mod P00011· FUNDING ONLY ACTION2018-10-01+$90,000$720,027RADIOPHARMACEUTICALS
Mod P00012· UNIQUE ENTITY ID OR LEGAL BUSINESS NAME CHANGE - NON-NOVATION2018-10-11+$0$720,027RADIOPHARMACEUTICALS
Mod P00013· OTHER ADMINISTRATIVE ACTION2019-08-02−$23,757$696,271RADIOPHARMACEUTICALS
Mod P00014· OTHER ADMINISTRATIVE ACTION2020-04-24−$6,539$689,732RADIOPHARMACEUTICALS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EQ4VSLH8RC33)

AwardOffice · PSC / listingNet obligationsFY
36C24826N0411248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$231,773FY2026
36C24126N0274241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$771,411FY2026
36C25226N0210252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$164,999FY2026
36C26126N0065261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$153,991FY2026
36C24825N0208248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$224,563FY2025
36C24125N0495241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$656,883FY2025

Other recipients under 6550 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25226F0375ABBOTT LABORATORIES INC.252-NETWORK CONTRACT OFFICE 12 (36C252)$38,016FY2026
36C25226N0484FISHER SCIENTIFIC COMPANY L.L.C.252-NETWORK CONTRACT OFFICE 12 (36C252)$28,264FY2026
36C25226N0438BECTON, DICKINSON AND COMPANY252-NETWORK CONTRACT OFFICE 12 (36C252)$21,300FY2026
36C25226F0238ABBOTT LABORATORIES INC.252-NETWORK CONTRACT OFFICE 12 (36C252)$31,680FY2026
36C25226N0266BIOMERIEUX INC252-NETWORK CONTRACT OFFICE 12 (36C252)$65,900FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69D16C0058_3600_-NONE-_-NONE- · retrieved 2026-09-26.